semaglutide and other weight loss medications Why weight-loss drugs became more popular than ever this year US FDA approves weight loss

2022;83(2):21m14022

GLP-1 receptor agonists slow gastric emptying, causing constipation in more than 1 in 10 people on higher doses (Wegovy, Saxenda)

Three has traditionally become to be the magic number

A lower ratio in people who use GLP-1 medications may point to a higher risk of developing NAION, which affects blood flow to the optic nerve

2.3 Gut-kidney interactions The gut-kidney axis is an emerging field of study that highlights the bidirectional communication between these two organs, with the gut microbiota playing a significant role in their function and disease

Meanwhile, distributions from the Novo Nordisk Foundation continue to rise as the organization becomes flush with cash from its 28% stake in the pharmaceutical company